Loading insider details...
Latest Form 4 (Nov 4, 2026): Other (see footnotes) of 14,059 SUPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Supernus, Inc. (SUPN) | Other (see footnotes) | 14,059 | n/a |
| Nov 4, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Other (see footnotes) | 9,129 | n/a |
| Nov 2, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 70,000 | n/a |
| Aug 14, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 1,250 | n/a |
| Jul 31, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,250 | n/a |
| Mar 10, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Exercise/Conversion | 3,000 | n/a |
| Mar 3, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 3,000 | n/a |
| Feb 26, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 2,500 | n/a |
| Feb 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 1,125 | n/a |
| Feb 20, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/Award | 17,500 | n/a |